Liven Pharmaceuticals just made a rights issue. Will this prove to be the last throw of the dice?
The pharmaceutical company has had a torrid history. The new development could prove to be its redemption
Macter gaining market share, and diversifying into cosmetics
The biopharmaceutical manufacturer saw revenue growth faster than industry average, and also plans to launch a GLP 1 product
Pakistan loses up to Rs50bn annually to unethical drug marketing, say DRAP officialsÂ
DRAP CEO says irrational drug use accounts for nearly a quarter of Pakistan’s total health budget and is accelerating antimicrobial resistanceÂ
Sales tax hike to 18% expected to raise medicine prices
Sales tax is also imposed on diagnostic kits/equipment across various specialties, including cardiology, neurology, oncology, and urologyÂ
Panadol costs more now. What has this meant for the pharma industry?
Haleon has benefited from the new drug pricing policy introduced by DRAP and it shows in its financial results
Pricing dispute causes shortage of critical medicine
Pharma companies stop, limit production of scores of essential and non-essential medicines as govt rejects demand for 38% hike in prices
Govt decision to increase medicine prices augurs well for domestic drugmakers: Fitch Solutions
Revenue generating opportunities for local pharmaceutical companies in Pakistan will improve following the decision by the government to increase the prices of medicines, said Fitch Solutions
Britain nears 500 million pound deal for Sanofi, GSK Covid-19 vaccine
LONDON: Britain is close to agreeing a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline (GSK) for 60 million doses of...
PPMA strongly refutes allegations against quality of Pakistani medicines
Pharmaceutical body defends industry standards, warns against harmful impact on exports and national reputation
Hoechst Pakistan to acquire products and trademarks from Sanofi affiliates
Board approves strategic acquisition to strengthen product portfolio and market position
Where did all the Burnol go?
The household product is missing from pharmacies in Pakistan. But its brand recall still holds
DRAP orders immediate recall of substandard veterinary injection
Zaktyl-20 batch found substandard; authorities warn of therapy failure and drug resistance risks
Pharma industry decides to slash prices of 395 essential drugs
'Prices will not increase if rupee remains stabilised, utility prices are maintained and rate of inflation is controlled'Â
KARACHI:Â Pakistan Pharmaceutical Manufacturers' Association (PPMA) on...
Ferozsons strikes deal with Gilead Sciences to produce generic HIV drugÂ
Ferozsons or its affiliates can manufacture and sell lenacapavir in 120 countriesÂ
BF Bioscience, pharma company owned by Ferozsons and Argentinian Bago Group, got a stellar response to its IPO. What lies ahead?Â
The pharma company, which has been exporting to countries like Indonesia, Belarus and Ukraine, saw book building at Rs 77/share and oversubscription of 3.4 times.
